Myriad Genetics

IPO

Genetic Testing | Advancing Health with Myriad Genetics

Myriad Genetics was founded in 1991, is headquartered in Salt Lake City, United States, lists 1001–5000 employees, and has $190.0M in recorded funding across 2 rounds.

Employees
1001–5000
Founded
1991
Business Model
B2B2C
Website
myriad.com
Total Funding
$190.0M
Last Round
$100.0M Venture RoundNov 2023
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Myriad Genetics is a leading genetic testing company founded in 1991, offering hereditary cancer, prenatal, oncology, and mental health genetic tests to help patients and clinicians detect, treat, and prevent disease. Its flagship MyRisk Hereditary Cancer Test screens 25 genes associated with significantly elevated cancer risk, serving patients, families, and healthcare providers worldwide.

Summary

Myriad Genetics is a Biotech company based in Salt Lake City, United States, founded in 1991. It lists 1001–5000 employees. It has raised $190.0M in total across 2 rounds, most recently a $100.0M Venture Round in Nov 2023. Investors include Bank of America, Wells Fargo and JPMorgan Chase.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Venture RoundVenture RoundNov 2023
$100.0M

Sign up to see all 3 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Acquisitions

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Myriad Genetics on Indexed.vc
<a href="https://indexed.vc/companies/myriad-genetics"><img src="https://indexed.vc/api/badge/company/myriad-genetics" alt="Myriad Genetics on Indexed.vc" width="260" height="76" /></a>